CTIS2023-507075-22-00招募中1 期
Safety, pharmacokinetics and pharmacodynamics study of Leucettinib-21 in healthy subjects, Down Syndrom and Alzheimer patients
Eurofins Optimed0 个研究点目标入组 120 人开始时间: 2023年9月1日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
1 期
Study to evaluate the effects of new drug of diabetes mellitus in healthy volunteers.CTRI/2016/01/006507Cadila Pharmaceuticals Ltd36
进行中（未招募）
1 期
A Pharmacokinetic, Pharmacodynamic and Safety Study of Single and Multiple Doses of Rabeprazole in Pediatric Subjects with GERD 1 to 11 Months old, InclusivePediatric subjects with GERDMedDRA version: 9.1Level: LLTClassification code 10018203Term: GERDEUCTR2008-000452-27-BEJanssen-Cilag International N.V.49
进行中（未招募）
1 期
Study of Rabeprazole in Pediatric Subjects aged 1 to 11 months with acid reflux diseasePediatric subjects with GERDMedDRA version: 13.1 Level: LLT Classification code 10018203 Term: GERD System Organ Class: 10017947 - Gastrointestinal disordersEUCTR2008-000452-27-GBJanssen-Cilag International N.V.49
进行中（未招募）
1 期
Safety, tolerability, and pharmacokinetics study of turoctocog alfa pegol injected under the skin in patients with haemophilia AEUCTR2016-002396-99-FRovo Nordisk A/S36
进行中（未招募）
1 期
Safety, tolerability, and pharmacokinetics study of turoctocog alfa pegol injected under the skin in patients with haemophilia AHaemophilia AMedDRA version: 19.0Level: LLTClassification code 10018938Term: Haemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2016-002396-99-DEovo Nordisk A/S48